HealthCERT continues to support the implementation of Ngā Paerewa Health and disability services standard NZS 8134:2021 (Ngā Paerewa). As part of the implementation and transition period, HealthCERT is running a regular survey to gather feedback from all stakeholders, including service providers, health professionals, people and whānau who use these services. This survey aims to check in on how the transition is going so we can identify the most useful guidance and training to offer....More
Tēnā koutou. Welcome.
Medsafe, the Medicines and Medical Devices Regulatory Authority of Aotearoa New Zealand, welcomes participants to take part in this survey about clozapine.
What is the survey aim? To gain important insights into experiences of people who take clozapine and from healthcare professionals who support people who take clozapine in New Zealand.
Who are we asking to participate? People who take...More
The Radiation Safety Act 2016 (the Act) is administered by the Manatū Hauora – the Ministry of Health (the Ministry).
Section 86(1) of the Act allows the Director for Radiation Safety (Director) to issue codes of practice. This is for the purpose of specifying technical requirements.
The Code of Practice for Diagnostic and Interventional Radiology ORS C1 (C1) first became effective as of 9 November 2018. Section 90(a) of the Act requires the Director to review a code of...More
The purpose of this questionnaire is to gather information about how New Zealand Health Survey results are shared, uncover which New Zealand Health Survey data products people find most useful, and identify ways to improve them. We are interested in hearing from people who use, or may potentially use, New Zealand Health Survey data.
This online questionnaire will take about 10-15 minutes. The results will be aggregated, and your data will remain confidential.
Feel...More
Manatū Hauora (the Ministry of Health) is seeking written feedback on this draft of its Long-term Insights Briefing (the briefing) by 5pm on 19 June 2023.
Precision health: Exploring opportunities and challenges to predict, prevent, diagnose, and treat disease more precisely in Aotearoa New Zealand: Public consultation on a draft long-term insights briefing
This briefing represents the start of a conversation about how we use current and emerging technologies toward precision...More
This document sets out proposed wording for a revised Code of Practice for Dental Radiology ORS C4 (the C4 Code) to be issued under the Radiation Safety Act 2016 (the Act).
Section 90(a) of the Act requires the Director for Radiation Safety (the Director) review a code of practice every five years.
Also, section 90(b) of the Act requires before reviewing a code of practice that the Director consult any person who the Director reasonably considers is likely to be affected by the...More
HealthCERT continues to support the implementation of Ngā Paerewa Health and disability services standard (NZS 8134:2021). As part of the implementation and transition period, HealthCERT is running a regular survey to gather feedback from all stakeholders, including service providers, auditing agencies, health professionals, people and whānau who use these services. The survey aims to gather feedback on your current level of understanding of Ngā Paerewa and identify which key areas...More
This consultation document presents, for public feedback, ACART’s thoughts about the matters that will, or might, need to be addressed in updated guidelines for human reproductive research.
The current guidelines for human reproductive research, titled Guidelines for Research on Gametes and Non-viable Embryos, were published in 2005. It is timely to review these now with a view to providing updated guidelines that still enable society to benefit from developments in ART while...More
As part of the next stage of the health reforms, we are developing a range of strategies to help guide our health system to achieve pae ora, healthy futures. One of those strategies is the Hauora Māori Strategy which will set the direction of the new health system for improving Māori health and wellbeing.
Manatū Hauora and Te Aka Whai Ora are developing the interim Hauora Māori Strategy as part of a suite of health strategies within the Pae Ora (Healthy...More
Manatū Hauora would like to hear from you about changes to the way smoked tobacco and vaping products are made and sold in Aotearoa (this includes vaping, heated tobacco and herbal smoking products).
Following recent updates to the Smokefree Environments and Regulated Products (Smoked Tobacco) Amendment Act, we are seeking your views on proposals to implement these changes, including a retail scheme (where products are sold), and low nicotine requirements for smoked tobacco in Aotearoa....More
Manatū Hauora (Ministry of Health) is seeking written feedback on the proposed topic of its Long-term Insights Briefing by 5pm on Friday 27th January 2023.
The proposed topic is:
Precision health: Exploring opportunities and challenges to predict, prevent, diagnose, and treat disease more precisely in Aotearoa New Zealand.
This is the first phase of a 2-phase public consultation approach to develop our briefing. You can make your submission by:
completing the ...More
The National Ethics Advisory Committee – Kāhui Matatika o te Motu (NEAC) is an independent advisor to the Minister of Health. NEAC has developed an update to its 2007 publication ‘ Getting Through Together: Ethical Principles for a Pandemic ’. The updated publication is called ‘Ethical Guidance for a Pandemic: Whakapuāwaitia e tatou kia puāwai tātoui’ . This online survey is seeking your feedback on the draft publication.
NEAC wants to know if the ideas contained within...More
The Contraception, Sterilisation and Abortion Act (CSA Act) was amended on 24 March 2020 to enable better access to abortion services.
Manatū Hauora - Ministry of Health has a team managing the ongoing implementation of this work.
Further information on the Act and the Ministry’s programme of work can be found at: ...More
Purpose of feedback survey:
This document seeks feedback from across the health system (TWO, NPHS, PHA) on ways to improve the draft publication, which is a part of the PHA healthy urban development kaupapa. The purpose of the healthy urban development kaupapa is to address the wider determinants of health through influencing urban development, planning, design and policy in this area. The Kaupapa therefore provides advice, evidence and guidance on the connections between our...More
ACART is pleased to present this consultation on Proposed Changes to the Guidelines for Extending the Storage of Gametes and Embryos. The proposed changes will address an apparent anomaly that requires a person, applying to extend the storage of embryos created from donated gametes, to obtain the consent of the gamete donors again.
The amendments will also make the Guidelines easier to understand and clearer about who needs to consent to the extension of storage in which situations.
...More
This Medsafe consultation seeks your feedback on a proposed new warning and advisory statement for the package labelling of ocular decongestants. These are medicines that provide temporary relief of redness and/or minor irritation in the eyes through narrowing of swollen blood vessels.
In June 2021 , the Medicines Adverse Reaction Committee (the Committee) noted that the Clear Eyes (naphazoline) 0.01% eye drops package label did not have a lower age limit for use. The...More
The Ministry of Health has drafted an ambitious new HIV Action Plan with support from organisations representing communities living with and affected by HIV and health sector representatives.
The HIV Action Plan is an exciting opportunity to increase the momentum of our HIV response and strive for an Aotearoa New Zealand where local HIV transmission is eliminated and people living with HIV have healthy lives free from stigma and discrimination.
We are already in a strong position to...More
The Health Information Standards Organisation (HISO) invites public comment on new draft standard HISO 10099:2022 NZ International Patient Summary (NZIPS) .
NZIPS specifies the makeup of a core personal health data set that covers health conditions, immunisations, medicines, allergies and adverse reactions, measurements, test results and care plans in its first edition.
The standard centres on a data set specification and outlines data...More
The Ministry of Health (the Ministry) invites submissions on proposed additions to the Schedule of Specified Prescription Medicines for Designated Registered Nurse Prescribers 2016.
The Ministry, on behalf of the Director-General, must consult with those people or organisations that may be affected by a change to the schedules before making a legal change by Gazette notice. The Nursing Council has agreed that these medicines are appropriate to be added to the list for...More
Whilst we a completing an annual report for the DE programme we thought it was timely to provide DEOG members with the opportunity to offer comments, views and suggestions about governance. The following 21 questions cover the areas of; governance performance, risk management, operations, DEOG meetings, DEOG membership, the DEOG TOR and a section for general comments. Thank you for taking the time to complete this survey.
This survey will take 10-15 minutes to complete and...More
The Digital Enablement Programme is committed to providing opportunities where you can provide your feedback. We want to know about your experience and perspectives on the support you received from the programme during the delivery of your project. Knowing what worked well and what can be improved helps us adapt, change and design accordingly.
We are particularly interested in what you initially planned and how this may have changed during the project. Understanding why...More
As COVID-19 and other pressures continue to impact our health sector, the National Cervical Screening Programme (NCSP) wants your input to determine how cervical screening is being affected in primary care, specifically with regards to sector capacity.
COVID-19 has impacted screening rates for all populations, but wāhine Māori and Pacific peoples have been inequitably affected. As people working in the health system, we share a vision of equitable screening programmes, where all...More
From July 2023, the primary test for cervical screening will change to a human papillomavirus (HPV) test. Self-testing with clinical oversight will be an option for all participants.
This survey aims to build on knowledge and resources, and input gathered previously, in order to determine what resources (pamphlets, web pages and other materials) for participants and their whānau will be required for the transition to HPV Primary Screening.
To gather initial requirements for this...More
Overview
The Ministry of Health (the Ministry) invites submissions on proposed additions to the schedule of specified prescription medicines for designated pharmacist prescribers.
The Ministry, on behalf of the Director-General, must consult with those people or organisations that may be affected by a change to the schedules before making a legal change by Gazette notice. The Ministry is doing a joint consultation, in partnership with the Pharmacy Council.
This submission...More
The Review of Radiation Safety Fees and Regulations sets out proposals to amend the Radiation Safety Regulations 2016 (the Regulations), including significant increases to application fees for radiation safety authorisations, minor amendments to existing exemptions and setting out the fees payable in a simple format.
This consultation is designed to provide sufficient information and time for people who are affected by the Regulations to make an informed contribution to...More
This Medsafe consultation proposes a new warning and advisory statement for the opioid class of medicines. The statement would be included in the Label Statements Database (LSD), which lists the warning and advisory statements that are required on medicines and related products package labels.
Opioid medicines are prescription medicines used to relieve moderate to severe acute pain and can also be used in palliative care. Most opioid medicines are also classified as controlled...More
The New Zealand Cancer Action Plan | Te Mahere mō te Mate Pukupuku o Aotearoa 2019-2029 provides a pathway to improve cancer outcomes for all New Zealanders with the objectives of building a system that delivers consistent and modern cancer care, equitable cancer outcomes, fewer cancers and better cancer survival, supportive care and end of life care.
The Anti-Cancer Therapy – Nationally Organised Workstreams (ACT-NOW) programme was launched in 2018 with the aim to develop a...More
